Back
Catalyst Pharmaceuticals Stock Price Chart
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Sell
38
CPRX
Catalyst Pharmaceuticals
Last Price:
21.38
Seasonality Move:
4.48%
7 Day Trial
ALL ACCESS PASS
$
7
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.- The current trend is moderately bearish and CPRX is experiencing slight selling pressure.
Catalyst Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 22.45 | Sell |
| 20-day SMA: | 22.03 | Sell |
| 50-day SMA: | 20.98 | Sell |
| 200-day SMA: | 17.41 | Buy |
| 8-day EMA: | 21.85 | Sell |
| 20-day EMA: | 21.86 | Sell |
| 50-day EMA: | 21.03 | Sell |
| 200-day EMA: | 18.13 | Buy |
Catalyst Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.25 | Buy |
| Relative Strength Index (14 RSI): | 41.98 | Sell |
| Chaikin Money Flow: | -136239 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.99 - 22.71) | Sell |
| Bollinger Bands (100): | (17.25 - 21.61) | Buy |
Catalyst Pharmaceuticals Technical Analysis
| Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Catalyst Pharmaceuticals Stock
Is Catalyst Pharmaceuticals Stock a Buy?
- Catalyst Pharmaceuticals share price is 20.82 while CPRX 8-day simple moving average is 22.45, which is a Sell signal.
- The stock price of CPRX is 20.82 while Catalyst Pharmaceuticals 20-day SMA is 22.03, which makes it a Sell.
- Catalyst Pharmaceuticals 50-day simple moving average is 20.98 while CPRX share price is 20.82, making it a Sell technically.
- CPRX stock price is 20.82 and Catalyst Pharmaceuticals 200-day simple moving average is 17.41, creating a Buy signal.
CPRX Technical Analysis vs Fundamental Analysis
Sell
38
Catalyst Pharmaceuticals (CPRX)
is a Sell
Is Catalyst Pharmaceuticals a Buy or a Sell?
-
Catalyst Pharmaceuticals stock is rated a Sell
The current Catalyst Pharmaceuticals [CPRX] share price is $20.82. The Score for CPRX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
Catalyst Pharmaceuticals Stock Info
Market Cap:
2.48B
Price in USD:
20.82
Share Volume:
1.12M
Catalyst Pharmaceuticals 52-Week Range
52-Week High:
24.27
52-Week Low:
13.00
Sell
38
Catalyst Pharmaceuticals (CPRX)
is a Sell
Catalyst Pharmaceuticals Share Price Forecast
-
What is the Catalyst Pharmaceuticals stock price today?
The Catalyst Pharmaceuticals stock price is 20.82 USD today. -
Will CPRX stock go up or go down?
Catalyst Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Catalyst Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Catalyst Pharmaceuticals is overvalued.
Is Catalyst Pharmaceuticals Stock a Buy?
- Catalyst Pharmaceuticals share price is 20.82 while CPRX 8-day exponential moving average is 21.85, which is a Sell signal.
- The stock price of CPRX is 20.82 while Catalyst Pharmaceuticals 20-day EMA is 21.86, which makes it a Sell.
- Catalyst Pharmaceuticals 50-day exponential moving average is 21.03 while CPRX share price is 20.82, making it a Sell technically.
- CPRX stock price is 20.82 and Catalyst Pharmaceuticals 200-day simple moving average is 18.13, creating a Buy signal.
Fundamental Analysis of Catalyst Pharmaceuticals
Is Catalyst Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $0.05 per share.
Technical Analysis of Catalyst Pharmaceuticals
Should I short Catalyst Pharmaceuticals stock?
- CPRX Moving Average Covergence Divergence (MACD) indicator is 0.25, suggesting Catalyst Pharmaceuticals is a Buy
- Catalyst Pharmaceuticals Relative Strength Index (RSI) is 41.98, which suggest Catalyst Pharmaceuticals is oversold
- The Bollinger Bands (25) for Catalyst Pharmaceuticals is (20.99 - 22.71), which suggest Catalyst Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Catalyst Pharmaceuticals is (17.25 - 21.61), which suggest Catalyst Pharmaceuticals is a Buy
* Catalyst Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.